VC fund profile · evidence-aware directory data
Octopus Ventures First Cheque II stages, portfolio and investment profile
Octopus Ventures announced a FIRST close of this UK/European pre-seed fund on 5 November 2026; capital actually committed is undisclosed. The fundraising target exceeds approximately €24 million converted at that day's ECB rate, not a completed fund size. The fund acquired Onstage's existing portfolio, including Serova Bio, but the manager's release conflicts on whether six or eight businesses transferred. LP identities, check sizes and final-close date are undisclosed.
Keep track of Octopus Ventures First Cheque II
Save this profile to your VCT watchlist for a quick return.
Stage-based planning range
$100K–$1M
This is a planning range inferred from stage coverage, not a firm-disclosed check size.
Methodology: Stage bucket inferred from the rounds a fund leads or invests in.
No firm-specific check-size disclosure is recorded.
Investment stages
Leads: Pre-Seed
Participates: Pre-Seed
Sector focus
Not recorded
Geography
London, United Kingdom
Founded Not recorded
Fund size / AUM
Not recorded
A separate fund-size evidence record is not yet available.
Portfolio in our directory
None yet
Linked startup profiles
Recent tracked investment
Not recorded
No dated round explicitly links this fund.
Rounds they lead
Rounds they invest
Last verified: 2026-11-09. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.